Medicine
Nimodipine 30 mg capsule
Nimodipine 30 mg capsule is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Capsules should be protected from light and freezing. Store at 20°to 25°C (68°…
Key facts
- Active ingredient (INN)
- Nimodipine
- Brand
- Sold under the generic name
- Strength
- 30 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 10 blister pack, 3 blister pack and 1 more
- Manufacturers
- Avet PharmaceuticalsIndiaBionpharma
- Origin register
- US FDA, United States
- Storage
- Capsules should be protected from light and freezing. Store at 20°to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C08CA06 Nimodipine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 November 2017
- Identifiers
- RxCUI 198037DailyMed set ID e65d5108-22a2-4d87-a78d-15606f3cc9e2, a323ebd8-ef1b-439b-93d1-ba73a5b0127dNDC 69452-209, 23155-512Application ANDA076740, ANDA077811
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 blister pack in 1 carton / 10 capsule, liquid filled in 1 blister pack | 23155-512-00 | Avet PharmaceuticalsIndia | 7 November 2017 |
| 3 blister pack in 1 carton / 10 capsule, liquid filled in 1 blister pack | 23155-512-30 | Avet PharmaceuticalsIndia | 7 November 2017 |
| 3 blister pack in 1 carton / 10 capsule, liquid filled in 1 blister pack | 69452-209-13 | Bionpharma | 21 November 2017 |
| 10 blister pack in 1 carton / 10 capsule, liquid filled in 1 blister pack | 69452-209-20 | Bionpharma | 21 November 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 December 1988 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Nimodipine
Clinical summary
Nimodipine is a dihydropyridine calcium channel blocker. It is available as oral solution and capsules. MedsAcross supplies Nimodipine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NimodipineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Nymalize prescribing information (Azurity Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Nimodipine 30 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.